Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer  Semini Sumanasuriya, Aurelius Omlin, Andrew Armstrong, Gerhardt Attard, Kim.

Slides:



Advertisements
Similar presentations
Differential drug responses of circulating tumor cells within patient blood Andrew D. Hughes, Jocelyn R. Marshall, Eric Keller, John D. Powderly, Bryan.
Advertisements

Volume 68, Issue 6, Pages (December 2015)
Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions: An Illustration for Metastatic Castration-
Volume 195, Issue 4, Pages e13-e14 (April 2016)
The PSA Era is not Over for Prostate Cancer
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017  Silke Gillessen, Gerhardt.
Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand  Bannakij Lojanapiwat, Choosak Pripatnanont,
Volume 65, Issue 6, Pages (June 2014)
Volume 60, Issue 2, Pages (August 2011)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
David Lorente, Karim Fizazi, Christopher Sweeney, Johann S. de Bono 
European Urology Focus
Volume 70, Issue 6, Pages (December 2016)
Volume 69, Issue 5, Pages (May 2016)
Volume 73, Issue 2, Pages (February 2018)
Volume 67, Issue 4, Pages (April 2015)
Volume 71, Issue 2, Pages (February 2017)
Volume 69, Issue 5, Pages (May 2016)
Volume 65, Issue 6, Pages (June 2014)
Advances in the Treatment of Metastatic Prostate Cancer
Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?
Prostate Cancer Epidemic in Sight?
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate.
Volume 71, Issue 1, Pages 1-3 (January 2017)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Prostate Cancer Detection: A View of the Future
Volume 66, Issue 3, Pages (September 2014)
Volume 70, Issue 5, Pages (November 2016)
Volume 69, Issue 6, Pages (June 2016)
Shaheen Alanee, Kasmintan Schrader, Kenneth Offit  European Urology 
Counselling the Prostate Cancer Patient
Volume 70, Issue 4, Pages (October 2016)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases  Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,
Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers  Pasquale Rescigno, David Lorente, David Dolling, Roberta Ferraldeschi, Daniel.
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Volume 50, Issue 5, Pages (November 2006)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
Volume 53, Issue 6, Pages (June 2008)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
European Urology Oncology
Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via Prostate-specific Membrane Antigen Positron Emission Tomography  Andrew.
Volume 71, Issue 6, Pages (June 2017)
Circulating tumor DNA: Solid data from liquid biopsies
DNA Repair in Prostate Cancer: Biology and Clinical Implications
Wilberto Nieves-Neira, J. Julie Kim, Daniela Matei 
Testicular Cancer Variations in Time and Space in Europe
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy  Matthew Mossanen, Kenneth.
Volume 70, Issue 6, Pages (December 2016)
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
Volume 74, Issue 3, Pages (September 2018)
How and When to Take Prostate Biopsies
Volume 75, Issue 3, Pages (March 2019)
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
European Urology Oncology
Treatment Options in Prostate Cancer Once Primary Therapy Fails
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer  Adam Sharp,
Jan Roigas  European Urology Supplements 
European Urology Oncology
Maximilian Burger, Ashish M. Kamat, David McConkey 
A Review of First-Line Treatment for Small-cell Lung Cancer
Presentation transcript:

Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer  Semini Sumanasuriya, Aurelius Omlin, Andrew Armstrong, Gerhardt Attard, Kim N. Chi, Charlotte L. Bevan, Aki Shibakawa, Maarten J. IJzerman, Bram De Laere, Martijn Lolkema, David Lorente, Jun Luo, Niven Mehra, David Olmos, Howard Scher, Howard Soule, Nikolas H. Stoecklein, Leon W.M.M. Terstappen, David Waugh, Johann S. de Bono  European Urology Oncology  Volume 1, Issue 2, Pages 151-159 (June 2018) DOI: 10.1016/j.euo.2018.02.009 Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 1 Expert voting on circulating biomarkers for advanced prostate cancer and their current utility in clinical practice. AR=androgen receptor; CNV=copy number variation; SNV=single-nucleotide variation; AR-V7=AR splice variant 7; cfDNA=cell-free DNA; CTC=circulating tumor cell. European Urology Oncology 2018 1, 151-159DOI: (10.1016/j.euo.2018.02.009) Copyright © 2018 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.